These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 9416844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
    Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B.
    Eur J Hum Genet; 2003 Apr; 11(4):288-96. PubMed ID: 12700603
    [Abstract] [Full Text] [Related]

  • 5. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 6. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
    Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E, Peretz H.
    Eur J Hum Genet; 2000 Aug 01; 8(8):590-6. PubMed ID: 10951521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Germline splicing mutations of CDKN2A predispose to melanoma.
    Loo JC, Liu L, Hao A, Gao L, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H, Hogg D.
    Oncogene; 2003 Sep 25; 22(41):6387-94. PubMed ID: 14508519
    [Abstract] [Full Text] [Related]

  • 9. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.
    Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ.
    Genes Chromosomes Cancer; 1997 May 25; 19(1):52-4. PubMed ID: 9135995
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.
    Rizos H, Becker TM, Holland EA, Kefford RF, Mann GJ.
    Oncogene; 1997 Jul 31; 15(5):515-23. PubMed ID: 9247305
    [Abstract] [Full Text] [Related]

  • 14. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A, Puig S, Malvehy J, Lázaro C, Lynch M, Gimenez-Arnau AM, Puig L, Sánchez-Conejo J, Estivill X, Castel T.
    J Med Genet; 1999 Jun 31; 36(6):490-3. PubMed ID: 10874641
    [Abstract] [Full Text] [Related]

  • 15. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
    Holland EA, Schmid H, Kefford RF, Mann GJ.
    Genes Chromosomes Cancer; 1999 Aug 31; 25(4):339-48. PubMed ID: 10398427
    [Abstract] [Full Text] [Related]

  • 16. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases.
    Levanat S, Situm M, Crnić I, Marasović D, Puizina-Ivić N, Pokupcić N, Musani V, Komar A, Kubat M, Furac I, Karija-Vlahović M, Krizanac S.
    Croat Med J; 2003 Aug 31; 44(4):418-24. PubMed ID: 12950144
    [Abstract] [Full Text] [Related]

  • 17. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S.
    Genes Chromosomes Cancer; 2000 Apr 31; 27(4):358-61. PubMed ID: 10719365
    [Abstract] [Full Text] [Related]

  • 18. Hereditary cutaneous melanoma.
    Platz A, Ringborg U, Hansson J.
    Semin Cancer Biol; 2000 Aug 31; 10(4):319-26. PubMed ID: 10966854
    [Abstract] [Full Text] [Related]

  • 19. CDKN2A mutations in melanoma families from Uruguay.
    Larre Borges A, Cuéllar F, Puig-Butillé JA, Scarone M, Delgado L, Badenas C, Milà M, Malvehy J, Barquet V, Núñez J, Laporte M, Fernández G, Levrero P, Martínez-Asuaga M, Puig S.
    Br J Dermatol; 2009 Sep 31; 161(3):536-41. PubMed ID: 19523171
    [Abstract] [Full Text] [Related]

  • 20. Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families.
    Hashemi J, Bendahl PO, Sandberg T, Platz A, Linder S, Stierner U, Olsson H, Ingvar C, Hansson J, Borg A.
    Genes Chromosomes Cancer; 2001 Jun 31; 31(2):107-16. PubMed ID: 11319798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.